Trading Signals: ABBV Stock Price Prediction and Forecast (Mon. Mar. 17, 2014 - Fri. Dec. 22, 2023)(AbbVie Inc.)
| ABBV latest price $89.8500 (-0.44%) ($89.4300 - $90.4000) on Tue. Dec. 24, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.28% (three month average) | RSI | 63 | Latest Price | $89.8500(-0.44%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | ABBV advances 1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support ABBV advance at 0% a week (0% probability) XLV(63%) SPLV(53%) VYM(53%) DIA(52%) IVE(51%) | Factors Impacting ABBV price | ABBV will decline at least -0.64% in a week (0% probabilities). VIXM(-36%) VXX(-14%) TLT(-14%) UUP(-0%) GLD(2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.64% (StdDev 1.28%) | Hourly BBV | -3.1 () | Intraday Trend | -0.6% | | | |
|
5 Day Moving Average | $89.5(0.39%) | 10 Day Moving Average | $89.07(0.88%) | 20 Day Moving Average | $88.11(1.97%) | To recent high | -0.4% | To recent low | 24.6% | Market Cap | $158.521b | | | | AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as as well as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL. |